Modified Lung Ultrasound Score in Evaluating the Severity of Covid-19 Pneumonia.


Journal

Ultrasound in medicine & biology
ISSN: 1879-291X
Titre abrégé: Ultrasound Med Biol
Pays: England
ID NLM: 0410553

Informations de publication

Date de publication:
08 2021
Historique:
received: 14 09 2020
revised: 20 04 2021
accepted: 21 04 2021
pubmed: 6 6 2021
medline: 10 7 2021
entrez: 5 6 2021
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019 (Covid-19), which has been declared as a pandemic by the World Health Organization. The aim of the study described here was to determine the severity of pneumonia and the clinical parameters related to a modified lung ultrasound score (mLUS) in patients with COVID-19 pneumonia. The study included 44 patients with proven COVID-19 pneumonia. Patients were divided into three groups on the basis of pneumonia severity: mild/moderate pneumonia (group I), severe pneumonia (group II) and critically ill patients (group III). It was determined that mLUS values in groups I-III were 6.51 ± 4.12, 23.5 ± 5.9 and 24.7 ± 3.9, respectively. mLUS values were significantly higher in group II and III patients than in group I patients. There was a positive relationship between mLUS and age and N-terminal pro-brain natriuretic peptide level and a negative relationship with P

Identifiants

pubmed: 34088529
pii: S0301-5629(21)00202-7
doi: 10.1016/j.ultrasmedbio.2021.04.023
pmc: PMC8086809
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2080-2089

Informations de copyright

Copyright © 2021 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest disclosure The authors have no conflicts of interest to disclose.

Références

J Infect. 2020 Jul;81(1):e95-e97
pubmed: 32305490
BMC Pulm Med. 2015 Aug 23;15:98
pubmed: 26298866
Ultrasound Med Biol. 2020 Aug;46(8):2094-2098
pubmed: 32409232
Anesth Analg. 2017 Feb;124(2):494-504
pubmed: 27669555
J Ultrasound. 2020 Jun;23(2):217-221
pubmed: 32297175
Ultrasound Med Biol. 2020 Aug;46(8):2090-2093
pubmed: 32451194
Am J Respir Crit Care Med. 2018 Aug 1;198(3):398-401
pubmed: 29557671
Ultrasound Med Biol. 2020 Nov;46(11):2927-2937
pubmed: 32798003
Invest Radiol. 2020 Jul;55(7):412-421
pubmed: 32304402
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
Crit Care Med. 2012 Jul;40(7):2064-72
pubmed: 22584759
Radiology. 2020 Jun;295(3):E6
pubmed: 32167853
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
Echocardiography. 2020 Apr;37(4):625-627
pubmed: 32239532
Crit Care. 2012 Feb 17;16(1):R30
pubmed: 22340202
Intensive Care Med. 2020 May;46(5):849-850
pubmed: 32166346
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Ann Transl Med. 2020 Feb;8(3):48
pubmed: 32154288

Auteurs

Hilmi Erdem Sumbul (HE)

Department of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Ayse Selcan Koc (AS)

Department of Radiology, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Arzu Pınar (A)

Department of Pulmonary Disease, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Muhammed Zubeyir Aslan (MZ)

Department of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Erdinc Gulumsek (E)

Department of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Hasan Koca (H)

Department of Cardiology, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Yurdaer Bulut (Y)

Department of Internal Medicine, Intensive Care Unit, Faculty of Medicine, Cukurova University, Adana, Turkey.

Emre Karakoc (E)

Department of Internal Medicine, Intensive Care Unit, Faculty of Medicine, Cukurova University, Adana, Turkey.

Tuba Turunc (T)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Edip Bayrak (E)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Huseyin Ali Ozturk (HA)

Department of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Akkan Avci (A)

Department of Emergency Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Ilker Unal (I)

Department of Biostatistics, Faculty of Medicine, Cukurova University, Adana, Turkey.

Yahya Kemal Icen (YK)

Department of Cardiology, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Mevlut Koc (M)

Department of Cardiology, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Ahmet Riza Sahin (AR)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.

Ramazan Azim Okyay (RA)

Department of Public Health, Faculty of Medicine, KahramanmarasSutcu Imam University, Kahramanmaras, Turkey. Electronic address: razim01@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH